Acute hepatitis A, abbreviated as HAV, is an acute infectious disease caused by the hepatitis A virus (HAV) entering the human body through the digestive tract. It belongs to category B infectious diseases and has a good prognosis, which can be completely cured. Acute viral hepatitis is currently treated with a comprehensive therapy of traditional Chinese and Western medicine, with appropriate medication given according to different conditions. Pay attention to adequate rest and reasonable nutrition in daily life, and avoid drinking alcohol, using hepatotoxic drugs, and other factors harmful to the liver.
Early in the disease, bed rest is required, and the amount of activity can be gradually increased as the symptoms are significantly relieved, jaundice subsides, and liver function improves significantly. After the symptoms disappear and liver function is normal, a rest and observation period of 1-3 months can be gradually resumed to work. However, regular follow-up examinations should be conducted every 1-2 years.
The sources of infection for acute hepatitis A are acute patients, subclinical infectors, and asymptomatic carriers. The incubation period is 15-45 days, and the peak of viral excretion is a few days before the onset of jaundice at the end of the incubation period. At this time, patients are the most dangerous sources of infection. The isolation period for acute hepatitis A is 3 weeks from the onset of the disease, and close contacts should be under medical observation for 4-6 weeks.